In Vitro Mineralisation of Tissue-Engineered Cartilage Reduces Endothelial Cell Migration, Proliferation and Tube Formation.
angiogenesis
bone tissue engineering
endochondral ossification
mesenchymal stromal cells
mineralisation
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
20 04 2023
20 04 2023
Historique:
received:
15
02
2023
revised:
14
04
2023
accepted:
18
04
2023
medline:
17
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Tissue engineering bone via endochondral ossification requires the generation of a cartilage template which undergoes vascularisation and remodelling. While this is a promising route for bone repair, achieving effective cartilage vascularisation remains a challenge. Here, we investigated how mineralisation of tissue-engineered cartilage affects its pro-angiogenic potential. To generate in vitro mineralised cartilage, human mesenchymal stromal cell (hMSC)-derived chondrogenic pellets were treated with β-glycerophosphate (BGP). After optimising this approach, we characterised the changes in matrix components and pro-angiogenic factors by gene expression analysis, histology and ELISA. Human umbilical vein endothelial cells (HUVECs) were exposed to pellet-derived conditioned media, and migration, proliferation and tube formation were assessed. We established a reliable strategy to induce in vitro cartilage mineralisation, whereby hMSC pellets are chondrogenically primed with TGF-β for 2 weeks and BGP is added from week 2 of culture. Cartilage mineralisation determines loss of glycosaminoglycans, reduced expression but not protein abundance of collagen II and X, and decreased VEGFA production. Finally, the conditioned medium from mineralised pellets showed a reduced ability to stimulate endothelial cell migration, proliferation and tube formation. The pro-angiogenic potential of transient cartilage is thus stage-dependent, and this aspect must be carefully considered in the design of bone tissue engineering strategies.
Identifiants
pubmed: 37190110
pii: cells12081202
doi: 10.3390/cells12081202
pmc: PMC10136546
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Trends Cell Biol. 2004 Feb;14(2):86-93
pubmed: 15102440
J Tissue Eng Regen Med. 2012 Jan;6(1):68-76
pubmed: 21305699
Arthritis Rheum. 2006 Oct;54(10):3254-66
pubmed: 17009260
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3311-6
pubmed: 20133604
J Cell Biochem. 1994 Jul;55(3):350-7
pubmed: 7962167
Calcif Tissue Int. 2005 May;76(5):379-84
pubmed: 15834504
Cartilage. 2021 Dec;13(2_suppl):559S-570S
pubmed: 34590881
Front Bioeng Biotechnol. 2020 Apr 17;8:327
pubmed: 32363188
J Bone Miner Metab. 2002;20(3):142-7
pubmed: 11984696
J Bone Miner Res. 2003 Aug;18(8):1430-42
pubmed: 12929932
J Bone Miner Res. 1999 Feb;14(2):273-80
pubmed: 9933482
Stem Cells. 2013 Nov;31(11):2420-31
pubmed: 23897668
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7251-6
pubmed: 20406908
Arthritis Res Ther. 2010;12(5):216
pubmed: 20959023
Eur Cell Mater. 2017 Sep 22;34:142-161
pubmed: 28937176
Front Cell Dev Biol. 2021 May 13;9:674084
pubmed: 34079804
J Mol Med (Berl). 1995 Jul;73(7):333-46
pubmed: 8520966
Histochem Cell Biol. 2003 Sep;120(3):235-41
pubmed: 12904969
Bone. 2018 Feb;107:10-17
pubmed: 29107125
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6840-5
pubmed: 18467492
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9637-42
pubmed: 15976027
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1381-7
pubmed: 18385273
Biomaterials. 2009 May;30(14):2816-25
pubmed: 19232714
Tissue Eng. 2004 Jul-Aug;10(7-8):978-86
pubmed: 15363155
Microsc Res Tech. 1998 Oct 15;43(2):191-204
pubmed: 9823004
J Bone Miner Res. 2006 May;21(5):735-44
pubmed: 16734388
Anat Rec. 1990 Jun;227(2):223-31
pubmed: 2350011
In Vitro Cell Dev Biol Anim. 1995 Apr;31(4):274-82
pubmed: 7795846
Am J Pathol. 2003 Jan;162(1):171-81
pubmed: 12507900
Biochem J. 2002 Jun 1;364(Pt 2):329-41
pubmed: 12023876
Ann N Y Acad Sci. 2003 May;995:109-16
pubmed: 12814943
Tissue Eng Part A. 2017 Dec;23(23-24):1466-1478
pubmed: 28756737
J Clin Med. 2019 Oct 03;8(10):
pubmed: 31623330
Tissue Eng. 2006 Jul;12(7):1721-31
pubmed: 16889503
Tissue Eng Part C Methods. 2009 Jun;15(2):285-95
pubmed: 19505182
Calcif Tissue Int. 2003 Aug;73(2):161-72
pubmed: 14565598
J Tissue Eng Regen Med. 2015 Aug;9(8):889-902
pubmed: 24916192
Stem Cells. 2016 Dec;34(12):2956-2966
pubmed: 27538760
Tissue Eng Part A. 2016 Oct;22(19-20):1176-1190
pubmed: 27604384
Stem Cells Transl Med. 2015 Aug;4(8):894-8
pubmed: 26025982
J Tissue Eng Regen Med. 2011 Oct;5(9):747-58
pubmed: 21953872
Bioengineering (Basel). 2018 Aug 12;5(3):
pubmed: 30103544
Biochem Biophys Res Commun. 2002 Apr 5;292(3):727-33
pubmed: 11922626
Biomaterials. 2006 May;27(14):2798-805
pubmed: 16430957
Crit Rev Eukaryot Gene Expr. 2009;19(3):219-33
pubmed: 19883366
BMC Musculoskelet Disord. 2011 Jan 31;12:31
pubmed: 21281488
Bone. 2004 Aug;35(2):535-42
pubmed: 15268906
Biomaterials. 2004 Mar;25(6):971-7
pubmed: 14615161
Angiogenesis. 2020 May;23(2):179-192
pubmed: 31754927
Front Bioeng Biotechnol. 2020 Mar 31;8:230
pubmed: 32296687
J Oral Biosci. 2022 Mar;64(1):18-25
pubmed: 34915120
Stem Cells Dev. 2016 Jan 15;25(2):123-38
pubmed: 26528828
J Theor Biol. 2008 Mar 7;251(1):137-58
pubmed: 18155732
Exp Cell Res. 1998 Feb 1;238(2):491-7
pubmed: 9473358
Tissue Eng Part A. 2009 Nov;15(11):3669-77
pubmed: 19499998
Eur Cell Mater. 2019 Sep 18;38:106-122
pubmed: 31532540
Arthritis Rheum. 2008 Apr;58(4):1076-85
pubmed: 18383360
Kidney Int. 2013 Feb;83(2):213-22
pubmed: 22913982